We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
New Drug Product for Friedreich Ataxia (FA) DT-216P2 with Favorable Nonclinical Pharmacokinetic and Injection Site Safety Profile; Complete GLP Studies by Year-end 2024 to Start Patient Trials in...
In Tuesday’s pre-market trading, U.S. index futures are pointing to a decline, reflecting investors’ caution as they analyze revelations from Nvidia’s artificial intelligence...
CARLSBAD, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today...
Seasoned Biotech Executive Pratik Shah Appointed as Chief Executive Officer to Lead Company Turnaround Current Cash and Securities of ~$290M Support Extended Five-Year Operating Runway Through...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.06 | 1.61290322581 | 3.72 | 3.965 | 3.51 | 241909 | 3.73654986 | CS |
| 4 | -0.26 | -6.43564356436 | 4.04 | 4.145 | 3.45 | 291303 | 3.78159089 | CS |
| 12 | 1.37 | 56.846473029 | 2.41 | 4.145 | 2.245 | 271187 | 3.2910332 | CS |
| 26 | 1.71 | 82.6086956522 | 2.07 | 4.145 | 1.96 | 342201 | 2.69191499 | CS |
| 52 | -2.54 | -40.1898734177 | 6.32 | 8.47 | 1.94 | 467830 | 3.02950124 | CS |
| 156 | -15.45 | -80.3432137285 | 19.23 | 29.16 | 1.94 | 328236 | 8.49930814 | CS |
| 260 | -24.22 | -86.5 | 28 | 50 | 1.94 | 326535 | 8.93833623 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
